Visceral obesity, but not central obesity, is associated with cardiac remodeling in subjects with suspected metabolic syndrome

被引:21
|
作者
Cho, D-H [1 ]
Kim, M-N [1 ]
Joo, H. J. [1 ]
Shim, W. J. [1 ]
Lim, D-S [1 ]
Park, S-M [1 ]
机构
[1] Korea Univ, Anam Hosp, Seoul, South Korea
关键词
Visceral obesity; Visceral fat; Cardiovascular disease; Metabolic syndrome; BIOELECTRICAL-IMPEDANCE ANALYSIS; ADIPOSE-TISSUE; ADIPONECTIN EXPRESSION; INSULIN-RESISTANCE; RISK-FACTORS; FAT; ECHOCARDIOGRAPHY; AREA;
D O I
10.1016/j.numecd.2019.01.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Metabolic syndrome (MetS) is a cluster of multiple risk factors including central obesity that may lead to cardiac damage and cardiovascular events. We investigated whether visceral obesity induces cardiac structural and functional remodeling independently from central obesity and other risk factors in subjects with suspected MetS. Methods and results: We studied 229 participants with suspected MetS. Visceral fat area (VFA) was measured by bioelectrical impedance analysis. Left ventricular (LV) mass index, early diastolic velocity of mitral annulus (e'), and LV global longitudinal strain (GLS) were measured by echocardiography. Subjects were categorized into high and low VFA group (VFA(h) and VFA(1)). MetS was more prevalent in the VFA(h) than in the VFA(1) (p = 0.004). The VFA(h) had a higher waist circumference (WC) than the VFA(1) (p < 0.001). LV mass index was higher, but e' and GLS were lower in the VFA(h) than in VFA(1) (all p < 0.05). VFA was well correlated with blood pressure, fasting blood glucose, triglyceride, high-sensitivity C-reactive protein and adiponectin (all p < 0.05). VFA was correlated to LV mass index, e', and GLS (all p < 0.05) and was independently associated with GLS after adjustment for other risk factors, including WC (p = 0.005). Conclusions: Visceral obesity assessed by VFA was well correlated with parameters of MetS. Visceral obesity, but not central obesity measured by WC, was independently associated with structural and functional cardiac remodeling in subjects with suspected MetS. It suggests that visceral obesity should be considered as an important risk factor for cardiac damage in dysmetabolic subjects. (C) 2019 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:360 / 366
页数:7
相关论文
共 50 条
  • [1] OSA, metabolic syndrome and CPAP: Effect on cardiac remodeling in subjects with abdominal obesity
    Grandi, Anna M.
    Laurita, Emanuela
    Marchesi, Chiara
    Maresca, Andrea M.
    Solbiati, Francesco
    Bernasconi, Antonella
    Marogna, Maurizio
    Salina, Claudio
    Nicolini, Eleonora
    Guasti, Luigina
    Colombo, Fausto
    Venco, Achille
    RESPIRATORY MEDICINE, 2012, 106 (01) : 145 - 152
  • [2] Is visceral obesity the cause of the metabolic syndrome?
    Després, JP
    ANNALS OF MEDICINE, 2006, 38 (01) : 52 - 63
  • [3] Relationship between central obesity and metabolic syndrome components
    Ignacio Coniglio, Raul
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2014, 48 (02): : 191 - 201
  • [4] VISCERAL OBESITY,MAY HAVE DIFFERENT EFFECTS ON METABOLIC SYNDROME PARAMETERS IN WOMEN AND MEN
    Demirbas, Berrin
    Gursoy, Gul
    Simsek, Meltem
    Bahsi, Remzi
    Kosar, Pinar
    Usta, Behice Merve
    ACTA MEDICA MEDITERRANEA, 2016, 32 (01): : 45 - 50
  • [5] Visceral obesity, skeletal muscle mass and resistin in metabolic syndrome development
    Paulina Rodriguez-Lopez, Carmen
    Cristina Gonzalez-Torres, Maria
    Cruz-Bautista, Ivette
    Najera-Medina, Oralia
    NUTRICION HOSPITALARIA, 2019, 36 (01) : 43 - 50
  • [6] Visceral obesity, but not metabolic syndrome, is associated with the presence of post-thrombotic syndrome
    Rattazzi, M.
    Callegari, E.
    Sponchiado, A.
    Galliazzo, S.
    Pagliara, V.
    Villalta, S.
    Pauletto, P.
    THROMBOSIS RESEARCH, 2015, 136 (02) : 225 - 228
  • [7] Serum osteocalcin in subjects with metabolic syndrome and central obesity
    Bador, Khalidah M.
    Wee, Lim D.
    Halim, Siti Aizon A.
    Fadi, Mohd Faris M.
    Santhiran, Premalatha
    Rosli, Nabila F.
    Mustafa, Norlaila
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2016, 10 (01) : S42 - S45
  • [8] Visceral Obesity and Metabolic Syndrome Are Associated with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
    Santos, Ana P.
    Santos, Ana C.
    Castro, Clara
    Raposo, Luis
    Pereira, Sofia S.
    Torres, Isabel
    Henrique, Rui
    Cardoso, Helena
    Monteiro, Mariana P.
    CANCERS, 2018, 10 (09)
  • [9] Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma
    Elliott, Jessie A.
    Reynolds, John V.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Visceral obesity, the metabolic syndrome, androgens and estrogens
    Gooren, Louis
    AGING MALE, 2006, 9 (02) : 75 - 79